Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
50.02
+1.27 (2.61%)
At close: Nov 6, 2026, 4:00 PM EST
50.00
-0.02 (-0.04%)
After-hours: Nov 6, 2026, 7:57 PM EST
Axogen Revenue
Axogen had revenue of $75.83M in the quarter ending September 30, 2026, with 26.22% growth. This brings the company's total for the last twelve months to $266.93M, up 24.32% year-over-year. In the year 2025, Axogen had annual revenue of $225.21M with 20.21% growth. That makes Axogen the 15,381st largest company in the world by revenue and 2,687th in the United States.
Revenue (ttm)
$266.93M
Revenue Growth
+24.32%
P/S Ratio
11.19
Revenue / Employee
$429,141
Employees
622
Market Cap
2.99B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 225.21M | 37.87M | 20.21% |
| Dec 31, 2024 | 187.34M | 28.33M | 17.81% |
| Dec 31, 2023 | 159.01M | 20.43M | 14.74% |
| Dec 31, 2022 | 138.58M | 11.23M | 8.81% |
| Dec 31, 2021 | 127.36M | 15.06M | 13.41% |
| Dec 31, 2020 | 112.30M | 5.59M | 5.24% |
| Dec 31, 2019 | 106.71M | 22.78M | 27.13% |
| Dec 31, 2018 | 83.94M | 23.51M | 38.91% |
| Dec 31, 2017 | 60.43M | 19.32M | 46.99% |
| Dec 31, 2016 | 41.11M | 13.78M | 50.41% |
| Dec 31, 2015 | 27.33M | 10.51M | 62.52% |
| Dec 31, 2014 | 16.82M | 5.87M | 53.62% |
| Dec 31, 2013 | 10.95M | 3.26M | 42.33% |
| Dec 31, 2012 | 7.69M | 2.84M | 58.61% |
| Dec 31, 2011 | 4.85M | 1.85M | 61.41% |
| Dec 31, 2010 | 3.00M | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.31B |
| Integer Holdings | 1.83B |
| LivaNova | 1.51B |
| Neogen | 884.00M |
| Inspire Medical Systems | 880.94M |
| iRhythm Holdings | 854.04M |
| TransMedics Group | 727.65M |
| UFP Technologies | 649.52M |
AXGN News
- 3 days ago - Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences - GlobeNewsWire
- 8 days ago - AxoGen price target raised to $56 from $52 at Leerink - TheFly
- 8 days ago - AxoGen price target raised to $58 from $55 at Lake Street - TheFly
- 8 days ago - AxoGen price target raised to $65 from $58 at Mizuho - TheFly
- 8 days ago - AxoGen price target raised to $60 from $55 at Canaccord - TheFly
- 8 days ago - AxoGen price target raised to $56 from $53 at H.C. Wainwright - TheFly
- 8 days ago - AxoGen price target raised to $60 from $50 at Barclays - TheFly
- 9 days ago - AxoGen price target raised to $60 from $55 at Jefferies - TheFly